skip to main content
Language:

1:30 PM, Abstract No. 108 - Prostatic arterial embolization, as an alternative to surgery, for patients with benign prostatic hyperplasia refractory to medical therapy: results in 500 cases

Pisco, J.M. ; Bilhim, T. ; Campos Pinheiro, L. ; Rio Tinto, H. ; Fernandes, L.C. ; Pereira, J. ; Duarte, M. ; Oliveira, A.

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S54-S54 [Peer Reviewed Journal]

Elsevier Inc

Full text available

Citations Cited by
  • Title:
    1:30 PM, Abstract No. 108 - Prostatic arterial embolization, as an alternative to surgery, for patients with benign prostatic hyperplasia refractory to medical therapy: results in 500 cases
  • Author: Pisco, J.M. ; Bilhim, T. ; Campos Pinheiro, L. ; Rio Tinto, H. ; Fernandes, L.C. ; Pereira, J. ; Duarte, M. ; Oliveira, A.
  • Is Part Of: Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S54-S54
  • Description: To evaluate the safety and efficacy of prostatic artery embolization (PAE) in 500 patients with benign prostatic hyperplasia (BPH) and indication to surgery. Five hundred consecutive patients with BPH and moderate to severe lower urinary tract symptoms (LUTS) after failure of medical therapy for at least 6 months and indication to surgery who underwent PAE. The age ranged between 45 and 89 years (mean 69.5 ± 8.3 years) and the prostate volume between 35 to 269cc (mean 92cc ± 56.3cc). Patients were evaluated before and at 1, 3, 6 and every 6 months after the procedure. Nonspherical polyvinyl alcohol (PVA) particles were used. The follow up control ranged from 3 to 52 months (mean 20.1 months). All patients were controlled at short-term at least at 3months, 319 patients over 1,5 years (mid term) and 48 patients over 3 years (long term). From the last group 12 patients have been followed over 4.5 years. There were 9 technical failures and 22 patients were lost to follow up. From the 469 controlled patients there were 107 (22.8%) clinical failures, 60 (12, 8%) at short term, 34 (10.6%) at mid- term and 13 (27.1%) at long term. Cumulative rates of clinical success at short term were at 3 months 87.2%, at medium term at 18 months 80.2%, and at long term at 36 months 72.3%. As major complication there was a bladder wall ischemia treated by simple surgery and an uncomfortable perineal pain lasting for 3months. Both patients remained without sequela. There was not any case of sexual dysfunction or urinary incontinence. PAE is a safe, well tolerated, and efficient outpatient procedure, an alternative to surgery, for patients with BPH refractory to medical therapy, with good short, mid-term and long term results, without sexual dysfunction or urinary incontinence.
  • Publisher: Elsevier Inc
  • Language: English
Back to results list

  • Implemented by: ABCD-USP USP   Social Network Logos: Freepik

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far